SEARCH

SEARCH BY CITATION

References

  • 1
    Al-Herz W, Bousfiha A, Casanova JL et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol 2011; 2:126.
  • 2
    de Vries E. Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists. Clin Exp Immunol 2006; 145:20414.
  • 3
    Lim MS, Elenitoba-Johnson KS. The molecular pathology of primary immunodeficiencies. J Mol Diagn 2004; 6:5983.
  • 4
    Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol 2007; 27:497502.
  • 5
    Yong PL, Boyle J, Ballow M et al. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology. Clin Immunol 2010; 135:25563.
  • 6
    Streiner DL, Norman GR. Health measurement scales : a practical guide to their development and use, 4th edn. Oxford/New York: Oxford University Press, 2008.
  • 7
    Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010; 125:135460 e4.
  • 8
    Skull S, Kemp A. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973–93. Arch Dis Child 1996; 74:52730.
  • 9
    Bonilla FA, Bernstein IL, Khan DA et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005; 94:S163.
  • 10
    Orange JS, Hossny EM, Weiler CR et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006; 117:S52553.
  • 11
    Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010; 137:2130.
  • 12
    Keszei AP, Novak M, Streiner DL. Introduction to health measurement scales. J Psychosom Res 2010; 68:31923.
  • 13
    Seger RA. Modern management of chronic granulomatous disease. Br J Haematol 2008; 140:25566.
  • 14
    Levinson DR. Intravenous immune globulin: medicare payment and availability OEI-03-05-00404: Office of the Inspector General, Department of Health and Human Services, 2007.
  • 15
    ESID diagnostic criteria for PID, 2005. Available at: http://www.esid.org/clinical-diagnostic-criteria-for-pid-73-0